Author Index


Arthritis & Rheumatism, Volume 63,
November 2011 Abstract Supplement

Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Chicago, Illinois November 4-9, 2011.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Y

Yabe YuichiroEarly Aggressive Intervention for Rheumatoid Arthritis Increases Rate of Remission Defined Using a Boolean Approach in Clinical Practice with Tocilizumab.
Yacyshyn ElaineHydroxychloroquine Retinopathy in Inflammatory Arthritis: A Retrospective Analysis in Canadian Patients.
 Patient-Driven On-Line Survey on Granulomatosis with Polyangiitis.
Yada ErikaEvidence for a Direct Role of Anti-Signal Recognition Particle Antibodies in the Pathogenesis of Necrotizing Myopathies.
Yadao AnthonyAmbulatory Resource Utilization for Gouty Arthritis and Gouty Arthritis Attacks.
 Health Care Resource Utilization Is Associated with Attack Frequency in Patients with Gouty Arthritis.
 Clinical Characteristics of Difficult-to-Treat Gout Patients: a Principal Components Analysis.
Yadin OraRace, Ethnicity and Gender Affect the Severity of Renal Outcomes in Patients with Pediatric Systemic Lupus Erythematosus: An Analysis of the CARRAnet Data At Baseline Visit.
Yagishita NaokoImportance of E3 Ubiquitin Ligase Synoviolin In Fibrogenesis.
Yagita HideoBlockade of Delta-like1 Suppresses Osteoclastgenesis and Arthritis.
Yague JordiClinical and Genetic Features of Autoinflammatory Syndromes in Hispanic Patients: The Chilean Experience.
Yair ShiraA Humanized Monoclonal Antibody Against a Surface Ligand of Mononuclear Cells Suppress Autoimmune Inflammatory Diseases by Upregulation of IL-10 Secretion.
Yajima NobuyukiAnti-CCP Titers Are Predictive of the Response to Biological Agents in Patients with Rheumatoid Arthritis.
Yalavarthi SrilakshmiVitamin D Deficiency, Interleukin 17, and Vascular Function in Rheumatoid Arthritis.
Yalcinkaya YaseminA Retrospective Analysis of Anti-TNF Treatment of 146 Ankylosing Spondylitis Patients According to Gender.
Yamada AkiraIn Situ Immune Complex (MPO-anti MPO antibody) and Complement 3 cause Glomerular Capillary Injury in Human MPO-ANCA Associated Glomerulonephritis.
Yamada HidehiroTranscription Intermediary Factor (TIF)-1 Is a New Dermatomyositis Autoantigen.
Yamada RyoA Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese.
Yamada SusumuTocilizumab Improves Arterial Stiffness Compared with Abatacept In Patients with TNF Blockers-Resistant Active Rheumatoid Arthritis.An Open Label Randomized Controlled Trial.
 Tocilizumab Monotherapy Improves BONE Mineral Density AS Well AS TNF Blockers PLUS Methotrexate with Methotrexate-RESISTANT Activerheumatoid Arthritis. AN OPEN-Label RANDOMIZED CLINICAL TRIAL. T-BONE TRIAL.
Yamada TaketoA New Derivative of Roxithromycin Modulates Immunological Responses and Ameliorates Collagen-Induced Arthritis.
Yamaguchi Ken-ichiSafety and Efficacy of Mizoribine in Patients with Connective Tissue Diseases Other Than Rheumatoid Arthritis.
 A Quality Indicator for Osteoporosis in a Japanese Hospital.
 Risk Factors for Positive Rheumatoid Factor Among 31,207 People without Rheumatologic Disorders.
Yamaguchi YukieA Peptide Derived From Endostatin Ameliorates Fibrosis Induced by TGF and Bleomycin in Multiple Pre-Clinical Models.
 A Membrane-Associated Adaptor Protein DOK5 Is Upregulated in SSc and Associated with IGFBP-5-Induced Fibrosis.
Yamaguci AyakoCharacterization of Anti Sjgren's Syndrome Nuclear Antigen-1 (SSNA-1) Novel Autoantibody in Patients with Primary Sjgren's Syndrome.
Yamamoto KazuhikoA Calcineurin Inhibitor FK506 Suppresses Joint Destruction in Patients with Early Rheumatoid Arthritis and Low Disease Activity.
 Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis.
 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
 Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments.
 A Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese.
 Contribution of a Kidney-Infiltrating CD4 T Cell Clone to Nephritis in Lupus-Prone Mice.
 Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate.
Yamamoto ShotaroNo Change in the Levels of PPD Reaction During Treatment with TNF Inhibitors in Rheumatoid Arthritis Patients in Japan, a Country with High Morbidity of Tuberculosis.
Yamamoto TatsuhiroEvaluation of 13c-Acetate Plus Lactulose Breath Test, a New Examination to Measure Intestinal Absorption in Patients with Systemic Sclerosis.
 Changes in Serum Receptor Activator for Nuclear Factor B Ligand and Osteoprotegerin After Glucocorticoid Therapy Reflect Regulation of Their Expression by Glucocorticoid in Osteoblasts in Vitro.
Yamamoto TatsuyaGene Polymorphisms of Signal Transducers and Activator of Transcription 4 and Tumor Necrosis Factor Receptor-Associated Factor 1 Predict Clinical Response to Disease-Modifying Anti-Rheumatic Drugs in Japanese Patients with Rheumatoid Arthritis.
Yamamoto TetsuyaInhibitory Effect of c-Fos/AP-1 Inhibitor T-5224 on the Levels of Cytokines and Chemokines in the Arthritic Lesion of Mice with Collagen-Induced Arthritis.
Yamamoto YukaFluorine-18 Fluorodeoxyglucose Positron Emission Tomography Is Useful for the Visualization of Reticulo-Endotheliao System and Prediction of Steroid-Resistant Cases in Adult Onset of Still's Disease.
Yamana JiroT-Cell-Related Cytokines Are Inhibited in Response to Tocilizumab in Patients with Rheumatoid Arthritis in Contrast with TNF-Inhibitor.
Yamana SeizoT-Cell-Related Cytokines Are Inhibited in Response to Tocilizumab in Patients with Rheumatoid Arthritis in Contrast with TNF-Inhibitor.
Yamanaka H.Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Japanese Patients with Active Rheumatoid Arthritis: A 12-Week Phase 2b Study.
 Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis: A Comparison Between Japanese and Global Populations Over 12 Weeks of Dosing in Phase 2b Studies.
 Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy or with Background Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Phase 2/3 Long-Term Extension Study.
Yamanaka HisashiNo Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan.
 Greater Physical Dysfunction Is a Negative Predictor for Achieving Boolean-Based Remission in Patients with Rheumatoid Arthritis Treated with Tocilizumab.
 Notch Pathway Is Activated in Systemic Sclerosis (SSc).
 Remission Induction by Etanercept (ETN) Plus Methotrexate (MTX) Combination Therapy Versus ETN Monotherapy in Patients with Active Rheumatoid Arthritis Despite MTX Treatment.
 Atorvastatin Attenuates Skin Fibrosis Through the PI3K Pathway.
 Decreased Plasma Ghrelin Levels in Patients with Systemic Sclerosis.
 Successful Maintenance of Remission Defined by the New ACR/EULAR Criteria Leads to Better Functional Outcomes in Rheumatoid Arthritis in Daily Practice, Especially in Patients with Early RA, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort.
 Risk Factors Associated with Incident Hip Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study.
 Classification of Two Subtypes in Adult-Onset Still's Disease.
 Impact of Tocilizumab Therapy for Remission Quartet in Rheumatoid Arthritisthe Result of 104 Weeks Follow up Data of REACTION study.
 Impact of Tocilizumab Therapy After Switching From Tumor Necrosis Factor (TNF) inhibitors Prevention of Joint Damage by Tocilizumab in Patients with Inadequate Response to Anti-TNF Therapies.
 Urinary Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis.
 Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis.
 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
 Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments.
 A Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese.
 Identification of Clinical and Genetic Factors That Influence the Response to Methotrexate in Japanese Rheumatoid Arthritis Patients: Genome-Wide Association Study.
 Anti-CADM-140 Antibody, Ferritin and IL-18 Are Associated with Disease Activity of Interstitial Lung Disease in Anti-CADM-140 Antibody-Positive Dermatomyositis.
 Discrepancy Between Boolean Remission and DAS28 Remission Is Dependent on the Differences in Number of Swollen Joints and Patient Global Assessment in Daily Practice, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort.
 Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate.
 Ischemic Colitis (IC) Associated with Rheumatic Diseases; A Colonoscopic Study of 23 IC Cases.
 Postmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In JapanFull Analysis Report of 7,901 Patients.
Yamano YoshihisaImportance of E3 Ubiquitin Ligase Synoviolin In Fibrogenesis.
Yamaoka KunihiroDopamine D2-Like Receptor Signaling Inhibits Human Osteoclast Differentiation From Monocytes.
 Tofacitinib Reduces Interleukin-6 and Matrix Metalloproteinase-3 Production and Inhibits Cartilage Destruction in Rheumatoid Arthritis.
 Relevance of Involvement of Tofacitinib in T Cell Subsets to Clinical Courses in Patients with Rheumatoid Arthritis.
 Discontinuation of Adalimumab Without Functional and Structural Progress After Attaining Remission in Patients with Rheumatoid Arthritis.
 A Multi-Biomarker Disease Activity Score (VectraDA algorithm score) Reflects Clinical Disease Activity and Tracks Response in a Japanese Rheumatoid Arthritis Population Treated with Anti-TNF Therapy.
 Tofacitinib Reduces Interferon- and Interleukin-17 Production From CD4 T Cells in Patients with Rheumatoid Arthritis.
Yamasaki MasaomiClinical Characterization of Extensive Interstitial Lung Disease in Rheumatoid Arthritis Patients.
Yamasaki SatoshiEvaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints.
 Functional Changes of Bone Marrow Derived Mesenchymal Stem Cell Through Adipogenesis. A Possible in Vitro Model of Bone Edema in Rheumatoid Arthritis.
Yamasaki YoshiokiTranscription Intermediary Factor (TIF)-1 Is a New Dermatomyositis Autoantigen.
Yamasaki YuichiCan Long-Term Use of Tocilizumab Induce Drug-Free Remission in Systemic Juvenile Idiopathic Arhtritis Refractory to Steroid Therapy?
 Measuring S100A12 and Vascular Endothelial Growth Factor Can Differentiate Familial Mediterranean Fever and Early Onset Sarcoidosis From Systemic Juvenile Idiopathic Arthritis.
Yamazaki HayatoBiological Agents in Rheumatoid Arthritis and Risk of Malignancy Results From the Nation-Wide Cohort Study in Japan.
Yan JamesA Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents.
 HM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice.
Yan MeiIntra-Articular Injection of the Selective IB Kinase Inhibitor NEMO-Binding Peptide Ameliorates Collagen Induced Arthritis by Inducing Regulatory T Cells and Alternatively Activated Macrophages.
Yanaba KoichiSerum Interleukin-9 Levels Are Increased In Patients with Systemic Sclerosis: Association with Lower Frequency and Severity of Pulmonary Fibrosis.
 IL-10-Producing Regulatory B Cells (B10 cells) Inhibit Intestinal Injury In Mice.
Yanagida TamikoEnhanced Expression of mRNA for Interleukin 6 and Tumor Necrosis Factor-Alpha In CD34 Cells of the Bone Marrow In Osteoarthritis.
Yanai RyoAnti-CCP Titers Are Predictive of the Response to Biological Agents in Patients with Rheumatoid Arthritis.
 Differential Regulation of Serum Cytokine Profiles In Patients with Rheumatoid Arthritis Treated with Tocilizumab: Possible Involvement of Macrophage Migration Inhibitory Factor.
Yanes JamesSubsequent Therapy of Patients with Biologic Response Modifiers or Disease-Modifying Antirheumatic Drugs After Coccidioidomycosis.
Yang EvaEvidence That HLA-B27-Induced Endoplasmic Reticulum (ER) Stress Produces Pro- and Anti-Osteoclastogenic Cytokines in Rats with Spondyloarthritis-Like Disease.
Yang Hyung-InAnti-TNF Agents May Accelerate the Remodeling of Hip Cartilage in Ankylosing Spondylitis.
 Synergy Between Adiponectin and Interleukin-1 on the Expression of Interleukin-6, Interleukin-8, and Cyclooxygenase-2 in Fibroblast-Like Synoviocytes.
Yang Il HwanA Novel SYK Specific Inhibitor for the Treatment of Rheumatoid Arthritis.
Yang Jui-ChenRheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis.
Yang KaiMolecular Imaging of Rheumatoid, Psoriatic and Osteoarthritis in the Hand.
Yang LihuaNiemann-Pick Type C2 Protein As a Negative Regulator of Innate Immunity: Inflammatory Cytokines and Eicosanoids.
Yang LisongIRF5 Activation in Monocytes of SLE Patients Is Triggered by Circulating Autoantigens Independent of Type I IFN.
Yang PingArIL-23 Upregulates IRF5 and Polarizes Inflammatory M1 Macrophages to Promote Inflammation in a Mouse Model of Arthritis.
 A Novel Role for Vitamin D in Immunosenescence: Is Enough Too Much for Nave CD8 T Cells?
 Fucosylation Inhibitor, 2-D-Gal, Promotes Human Synovial Fibroblast Apoptosis and Is a Potent Suppressor of Arthritis in a TNF- Tg Mouse Model In Vivo.
 Rebalancing the IL-23/Th17 Axis and Regulatory T Cells in Arthritis by Depleting IRF5 IL-23 M1 Macrophages Using An Anti-Human DR5 Antibody.
Yang ShuoDerivation and Validation of An Infection Risk Score to Predict the Risk of Serious Infections for Rheumatoid Arthritis Patients.
Yang XiaoningHM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice.
Yano ToshiroClinical Efficacy of Infliximab Is Maximized When Both Circulating TNF and IL-6 Are Suppressed In the Treatment of Rheumatoid ArthritisResults From the RISING Study.
Yao ChunxiangA Novel Human Autoantigen Induces T and B Cell Responses in Patients with Antibiotic-Refractory Lyme Arthritis.
Yao JianhuaFully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Reliability of Volume and Height Measures.
 Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Validity of Volume and Height Measures.
Yao LawrenceFully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Validity of Volume and Height Measures.
 Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Reliability of Volume and Height Measures.
Yao QingpingTumor Necrosis Factor Receptor Associated Periodic Fever Syndrome: A Case Series with Characteristic Features.
 Characterization of a New Category of Autoinflammatory Disease Associated with Nucleotide Oligomerization Domain2 Gene Mutations: An Expanded Cohort Study.
Yao YihongIdentification of microRNA-31 as a Novel Regulator Contributing to Impaired IL-2 Production in T cells From Patients With Systemic Lupus Erythematosus.
 Identification of Activated Cytokine Pathways in the Blood of Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients.
 Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients Share Activation of a Common Type I Interferon Pathway.
YAP Desmond YHBinding of Serum IgG to Human Mesangial Cells and Its Correlation with Disease Activity in Patients with Lupus Nephritis.
Yaqub AaliyaEffect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study.
Yarlagadda SushmaDNA Methylation Regulates Gene Expression in CD4CD28- T Cells Through Micrornas.
Yasuda ShinsukeRole of Apolipoprotein B100 and Oxidized Low-Density Lipoprotein in Anti-beta2 Glycoprotein I Induced Tissue Factor Expression on Monocytes.
 HLA-DRB501:05 Is a Risk Factor for Systemic Sclerosis with Interstitial Lung Disease.
Yasukawa MasakiAnalysis of the Bioactive Molecules That Promote the Induction of Human Tolerogenic Dendritic Cells.
 Lysophosphatidylcholine Enhances Suppressive Function of Human Naturally Occurring Regulatory T Cells Through TGF-Beta Production.
Yasumura JunkoCan Long-Term Use of Tocilizumab Induce Drug-Free Remission in Systemic Juvenile Idiopathic Arhtritis Refractory to Steroid Therapy?
Yasuoka HidekataImpaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells In Patients with Systemic Sclerosis.
 A Membrane-Associated Adaptor Protein DOK5 Is Upregulated in SSc and Associated with IGFBP-5-Induced Fibrosis.
Yates AllenSerum Cystatin C Is Affected by Inflammation and Renal Dysfunction in Patients with Systemic Lupus Erythematosus.
Yau IvannaDistinct Phenotypical Clusters In Childhood Inflammatory Brain Diseases: Implications for Diagnostic Evaluation.
 Vessel Remodeling in Childhood Primary CNS Vasculitis: Impact of Corticosteroid Therapy.
Yau Michelle S.Heritability and Linkage of Radiographic Progression of Hip and Knee Osteoarthritis: Results From the Longitudinal Component of the Genetics of Generalized Osteoarthritis Study.
Yau Wing HoiSteroid Injection for Plantar Fasciitisa Placebo-Controlled Trial.
Yavuz SuleDual Effects of Testosterone in Behcet's Disease: Implications for a Role in Disease Pathogenesis.
Yazawa K.Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis: A Comparison Between Japanese and Global Populations Over 12 Weeks of Dosing in Phase 2b Studies.
Yazdany JinoosCardiovascular Risk Assessment and Management in a Nationally Representative Sample of Routine Ambulatory Visits for Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus.
 Extra-Articular Manifestations of Rheumatoid Arthritis in An Ethnically Diverse Cohort: Prevalence and Clinical Associations.
 Effects of Pediatric-Onset Systemic Lupus Erythematosus on Final Linear Height: Evidence From a Large Observational Cohort.
 Physical Activity, Body Composition, and Cognitive Impairment Among Women with Systemic Lupus Erythematosus.
 Quality of Care for Common Comorbidities Among Patients with Rheumatoid Arthritis: An Analysis of HEDIS Data.
 Effect of Health Insurance Coverage on Quality of Care in SLE.
 Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes.
 Cardiovascular Disease and Cognitive Dysfunction in Systemic Lupus Erythematosus.
Yazici HasanManagement and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center.
 The Table-1 p Value Issue; Baseline Group Comparison Is Inappropriately Omitted in Non-Randomized Studies.
 Some Manifestations Disappear Earlier Than Others in Behcet's Syndrome.
 A Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis.
Yazici YusufA Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis.
 Comparative Effectiveness and Time to Response Among Abatacept, Adalimumab, Etanercept and Infliximab for the Treatment of Rheumatoid Arthritis in a Real World Routine Care Registry.
 2010 American College of Rheumatology/European League Against Rheumatism Rheumatoid Arthritis Criteria Classifies 67 of Systemic Lupus Erythematosus and 38 of Psoriatic Arthritis As Rheumatoid Arthritis: Implications for Real World Use.
 A Self-Report RADAI (Rheumatoid Arthritis Disease Activity Index) Count of Painful Joints Can Be Informative in Patients with Rheumatic Diseases Other Than Rheumatoid Arthritis.
 Assessment of Disease Activity in Behcet Disease: Comparison of Behcet's Disease Current Activity Form (bdcaf), Behcet's Syndrome Activity Score (bsas) and Routine Assessment of Patient Index Data (rapid) 3 Scores.
 Difference of Manifestations and Treatment Among Behcet's Syndrome Patients in the United States and Japan.
 Ethnic Minority Rheumatoid Arthritis Consortium: A Clinical Registry of Minority Patients with Rheumatoid Arthritis.
 Disease Activity Levels and Treatment Patterns Amongst Ethnic Minority Rheumatoid Arthritis Consortium Patients.
 Comparative Efficacy and Tolerability of Biologic Therapies in Early Rheumatoid Arthritis Utilizing a Bayesian Approach.
 Low Levels of Formal Education Generally Are As Significant As High Age and Long Duration of Disease to Identify Poor Clinical Status in Patients with Most Rheumatic Diseases.
 Scores for Sleep, Anxiety, and Depression on the Multidimensional Health Assessment Questionnaire (MDHAQ) in the Patient-Friendly HAQ Format Are Higher Than for Any of the 8 Traditional HAQ Queries to Identify Problems in Patients with Rheumatic Diseases.
 Assesment of Disease Activity in Ankylosing Spondylitis: Comparison of Rapid3, Basdai, Basfi, and Asdas Scores in Routine Care.
 Association of ACR Clinical Responses with CDAI (Clinical Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) Indices of Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol Plus Methotrexate.
 Efficacy of Tanezumab Compared with Non-Steroidal Anti-Inflammatory Drugs in Patients with Knee or Hip Osteoarthritis (NCT00809354).
 RAPID3 Remission Vs New ACR Rheumatoid Arthritis Remission Criteria: RAPID3 Has Similar Utility and May Be Used in Everyday Clinical Care.
 Patients Whose Global Estimates Are Higher Than Their Physician's Global Estimates Are More Likely to Be Female, Have Fewer Years of Formal Education, and Higher RAPID3 (Routine Assessment of Patient Index Data) Scores.
 Routine Assessment of Patient Index Data-3 (RAPID3) Is Informative in Patients with All Rheumatic Diseases to Depict Patient-Reported Information As Quantitative Data, Rather Than As Narrative Descriptions.
 Clinical Response At Months 16 Can Predict Likelihood of Achieving Remission in Abatacept Plus Methotrexate-Treated Patients with Early Rheumatoid Arthritis.
Ye S.Q.Decreased Expression of Nicotinamide Phosphoribosyltransferase (NAMPT) in Active Juvenile Idiopathic Arthritis Patients Receiving Methotrexate.
Ye XiangyangSerum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring.
Yeaw JasonComparing Costs of Tumor Necrosis Factor Blockers Per Treated Patient for Psoriatic Arthritis Using Real-World Data in US Managed Care.
 Costs of Tumor Necrosis Factor Blockers Per Treated Rheumatoid Arthritis Patient Using Real-World Drug Data in US Commercially-Insured Population.
Yee Chee-SengDevelopment of Damage and Death in a Large Cohort of SLE Patients.
 The BILAG-2004 Systems Tallya Novel Way of Analysing the BILAG-2004 Scores.
 Longitudinal Assessment of SLE Disease Activity: BILAG-2004, SLEDAI-2000 or Both?
Yeganeh LadanIs Dietary Intake of Patients with Systemic Lupus Erythematosus Adequate?
Yeh Li-tainPharmacokinetics, Efficacy and SAFETY of Lesinurad, a Novel URAT1 Inhibitor, In Individuals with Mild to Moderate Renal Impairment.
Yelin EdwardCardiovascular Risk Assessment and Management in a Nationally Representative Sample of Routine Ambulatory Visits for Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus.
 Physical Activity, Body Composition, and Cognitive Impairment Among Women with Systemic Lupus Erythematosus.
 Quality of Care for Common Comorbidities Among Patients with Rheumatoid Arthritis: An Analysis of HEDIS Data.
 Effect of Health Insurance Coverage on Quality of Care in SLE.
 Long-Term Mental Health Outcomes in Pediatric-Onset Systemic Lupus Erythematosus.
 Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes.
 Identifying Obesity in Rheumatoid Arthritis: Current BMI Definition of Obesity Does Not Accurately Reflect Body Composition.
Yelin Edward H.C-Reactive Protein Associated with Depression in Patients with Rheumatoid Arthritis.
 Cardiovascular Disease and Cognitive Dysfunction in Systemic Lupus Erythematosus.
Yeremenko NataliyaIdentification of Robust and Disease-Specific Stromal Alterations in Spondyloarthritis Synovitis.
 Serum Biomarkers to Predict Clinical Response in Proof-of-Concept Trials in Spondyloarthritis.
Yerges-Armstrong LauraAssociation of Candidate Single Nucleotide Polymorphisms with Radiographic Knee Osteoarthritis in African-Americans: Data From the Genetic Components of Knee Osteoarthritis Study.
 Heritability and Linkage of Radiographic Progression of Hip and Knee Osteoarthritis: Results From the Longitudinal Component of the Genetics of Generalized Osteoarthritis Study.
Yeung Rae SMCharacterization of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis.
 Use of IntraArticular Steroid Injection in a Large Cohort of Children with Oligoarticular Juvenile Idiopathic Arthritisthe ReACCh Out Study.
 Treatment Delay in Kawasaki Diseasethe Role of Non-Traditional Risk Factors.
Yew MargaretNon-Calcified Coronary Plaque in Systemic Lupus Erythematosus Quantitative Analysis.
Yi NengjunTransforming Growth Factor- Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor- Signaling and Risk for Systemic Sclerosis.
Yigla MordehaiEfficacy and Safety of Intravenous Cyclophosphamide In the Treatment of Scleroderma Lung Disease: 7-Year Follow-up.
Yildiz YasarEvaluation of Circulating Endothelial and Platelet Microparticles In Men with Ankylosing Spondylitis.
Yilmaz SedatAssessment of Disease Activity in Behcet Disease: Comparison of Behcet's Disease Current Activity Form (bdcaf), Behcet's Syndrome Activity Score (bsas) and Routine Assessment of Patient Index Data (rapid) 3 Scores.
 Assesment of Disease Activity in Ankylosing Spondylitis: Comparison of Rapid3, Basdai, Basfi, and Asdas Scores in Routine Care.
Yilmaz V.Genome-Wide Expression Profiling of CD14 Monocytes in Behcet's Disease: An Upregulated TGF-b Signaling and N-Methyltransferase Activity.
Yilmaz ZevcetFrequency of Pulmonary Arterial Hypertension Is Not Increased in Takayasu's Arteritis.
Yim Cheuk-wanLow Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis.
Yim Cheuk-WanInfliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial.
Yin HongenMatriptase Dificency and Primary Sjogren Syndrome Induction: From Patients to Mice.
Ying JunHLA DQB103:02 Is a Marker for Severity of Interstitial Lung Disease in Systemic Sclerosis.
 Behavior, Executive and Perceived Neuropsychological Functioning with Childhood-Onset Systemic Lupus ErythematosusResults of a Best-Friend Controlled Study.
 A Functional IRF5 Variant Predicts Prognosis in Patients with Systemic Sclerosis.
 The Pediatric Automated Neuropsychological Assessment Metrics Has Reproducibility and Criterion Validity in Childhood-Onset Lupus.
 Immunochip Genotyping of 1,884 Systemic Sclerosis Cases and 4,325 Controls Reveals Novel Associations.
Ying King YeeEffect of Raloxifene, a Selective Estrogen Receptor Modulator, on Disease Activity, Flare and Vascular Biomarkers in Patients with Systemic Lupus Erythematosus (SLE): A 12-Month Double-Blinded Randomized Controlled Trial.
 Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis.
 Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial.
Yip JonathanClinical-Pathological Correlates of Proliferative Lesions in Lupus Nephritis.
Yip PaulIncidence and Standardized Incidence Ratio (SIR) of Suicide in Southern Chinese Patients with Rheumatic Diseases in Hong Kong, China: 19992010.
Yli-Kerttula TimoCorrelation of 18fFDG PET Assessments with Disease Activity and Markers of Inflammation in Patients with Early Rheumatoid Arthritis Following Initiation of Antirheumatic Therapy.
Yocum David E.Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis.
 A Plasmablast Molecular Biomarker for Reduced Clinical Benefit From Anti-CD20 Therapy in Rheumatoid Arthritis.
Yoguim Marcelo I.Measurement of Pain Perception in Children and Adolescents with Musculoskeletal Pain.
Yokoe IsamuDetection of Left Ventricular Regional Dysfunction by Using Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients without Cardiac Symptoms; Comparison Between Non-Biologic DMARDs and Biologics Groups.
Yokogawa NaotoTo Screen Remission without Formal Joint Count: Analysis of Routine Assessment of Patient Index Data 3 in Japanese National Database.
 New Index to Assess the Improvement From the Worst Rheumatoid Arthritis Activity without Formal Joint Count.
 Response to Hydroxychloroquine in Japanese Patients with Cutaneous Lupus Erythematosus Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index.
Yokosawa MasahiroEvaluation of Activity, Making Diagnosis and Prediction of Future Bone Destruction by Using Low Field Compact Magnetic Resonance Imaging Machine in Patients with Rheumatoid Arthritis.
Yokota KazuhiroThe Pattern-Recognition Receptor NOD1 Promotes Production of Inflammatory Mediators in Different Cell Types of the Synovium in Rheumatoid Arthritis.
Yokota ShumpeiMycophenolate Mofetil (MMF) Versus Azathioprine As Maintenance Therapy Combined with Monthly Intravenous Cyclophsophamide (IVCY) in Juvenile Lupus Nephritis.
 Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
Yokoyama WakaChemerin Activates Fibroblast-Like Synoviocytes In Patients with Rheumatoid Arthritis.
Yomogida KentaroCell Penetrating Recombinant Foxp3 Protein Enhances Treg Function, Suppresses Th17 Cells and Ameliorate Arthritis.
Yona EliyahuActivation of c-Jun N-Terminal Kinase and Extracellular Signal-Regulated Kinase Predicts Damage in Systemic Lupus Erythematosus.
Yonemoto YukioDirect Comparison of Four Biologics in Biologic-nave Rheumatoid Arthritis Patients.
Yong HarryNitrated Nucleosome Levels in Patients with Systemic Lupus Erythematosus Associations with Ethnicity and Autoantibody Status.
 Nitrated Nucleosome Levels in Patients with Systemic Lupus ErythematosusAssociations with Disease Activity.
Yoo BinThe Role of Sufficient Starting Dose of Steroids in Adult-Onset Still's Disease.
 Efficacy of Combined Treatment with Allopurinol and Benzbromarone in Gout Patients with Chronic Renal Impairment.
 The Influence of Interleukin-32 on Osteoclastogenesis, with a Focus on Fusion-Related Genes.
Yoo Dae-HyunDo Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability?
 Free Interleukin 18 As a Predictor of Remission and Flare up in Adult-Onset Still's Disease Patients.
 What Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis?
Yoo Myung ChulSynergy Between Adiponectin and Interleukin-1 on the Expression of Interleukin-6, Interleukin-8, and Cyclooxygenase-2 in Fibroblast-Like Synoviocytes.
Yoo Wan-HeeInhibitory Effects of 1`,2`-Dihydrorotenone On Osteoclast Differentiation and Bone Resorption.
 Interesting Roles of IL-1 in Osteoclast Differentiation.
Yood Robert A.Characterization and Management of Infusion Reactions in Refractory Chronic Gout (RCG) Treated with Pegloticase (PGL).
Yoon Bo YoungWhat Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis?
 Do Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability?
 Treatment of Chemotherapy-Related Arthropathy with Disease Modifying Antirheumatic Drugs: Results of An Open-Labeled Multicenter Pilot Study.
Yoon Chong-HyeunPrevalence and Associated Factors for Asymptomatic Pulmonary Arterial Hypertension in Patients with Systemic Lupus Erythematosus.
Yoon Chong-HyunSerum Leptin Levels Are Associated with the Presence of Syndemophytes in Male Patients with Ankylosing Spondylitis.
Yoon GraceClinical Predictors Associated with Severe Radiographic Sacroilitis in Axial Spondyloarthritis.
Yoon HosungSerum Leptin Levels Are Associated with the Presence of Syndemophytes in Male Patients with Ankylosing Spondylitis.
 Ultrasonographic Evaluation of Hand and Wrist in Systemic Lupus Erythematosus without Arthralgia.
 Prevalence and Associated Factors for Asymptomatic Pulmonary Arterial Hypertension in Patients with Systemic Lupus Erythematosus.
 Apolipoprotein M Polymorphism Is a Novel Risk Factor for Dyslipidemia in Rheumatoid Arthritis: A Possible Link Between Disease Susceptibility and Dyslipidemia.
Yoshida HirotoIL-6 Blockade Augments the Therapeutic Effect of MTX in Mice with Glucose-6-Phosphate Isomerase-Induced Arthritis.
Yoshida KazukiDifference of Manifestations and Treatment Among Behcet's Syndrome Patients in the United States and Japan.
 Tocilizumab and Tumor Necrosis Factor Inhibitors in Biologic Switchers: Similar Drug Survival and Safety with Different Infection Profile in Routine Practice.
Yoshida KohsukeTNF Modulates the Expression of Circadian Clock Genes in Rheumatoid Synovial Cells.
Yoshifuji HajimeClinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide.
Yoshikawa HidekiAssociation of Pinch Strength with Hand Dysfunction, Finger Deformities and Contact Points In Patients with Rheumatoid Arthritis.
 Enhanced Expression of mRNA for Interleukin 6 and Tumor Necrosis Factor-Alpha In CD34 Cells of the Bone Marrow In Osteoarthritis.
 Comparison of Cytokine Levels in the Synovial Joint Fluid Between Rapidly Destructive Coxopathy, Hip Osteoarthritis, Rheumatoid Arthritis, and Hip Oseteonecrosis.
 Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Improves a Bone Resorption Marker in Postmenopausal Women with Rheumatoid Arthritis.
Yoshimi RyusukeUltrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis.
 Bach1 Regulates Osteoclastogenesis Via Heme Oxgenase-1 Dependent and Independent Pathways.
Yoshimoto KeikoAbnormalities in a JAK-STAT Pathway Are Involved in the Aberrant Production of IL-6 by BAFF-Stimulated Peripheral Monocytes of Patients with Primary Sjgren's Syndrome.
Yoshinari Natalino H.Abnormal Morphology and Excessive Synthesis of Collagen V Affects Skin Thickness and Disease Activity in Systemic Sclerosis.
Yoshinari ToruClinical Efficacy of Infliximab Is Maximized When Both Circulating TNF and IL-6 Are Suppressed In the Treatment of Rheumatoid ArthritisResults From the RISING Study.
 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
 Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments.
Yoshio TakuThe Intrathecal Production of IL-6, IL-8, IP-10, MCP-1 and G-CSF Increases More Highly Than the Serum Production in Patients with Central Neuropsychiatric Lupus Erythematosus.
 No Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan.
Yoshitaka TeruhitoSH3BP2 Cherubism Gain-of-Function Mutation Exacerbates Inflammation and Bone Erosion in Collagen Induced Arthritis.
Yoshiura Koh-ichiroProteasome Disability Syndrome: An Analysis of the Pathogenesis of a New Autoinflammatory Syndrome, Nakajo-Nishimura Syndrome.
You DanielClinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Systemic Sclerosis Patients.
You MinSwitching of Biologic Disease-Modifying Antirheumatic Drugs During the First Year in Patients with Rheumatoid Arthritis in a Real-World Setting.
 Real-World Switching Patterns in Rheumatoid Arthritis Patients Receiving Abatacept, Adalimumab, Etanercept or Infliximab As Second-Line Biologic Therapy.
Youinou PierreA Step Toward New Diagnostic Criteria in Sjgren's Syndrome: Contribution of Major Salivary Gland Ultrasonography and Blood B-Cell Subset Profiling.
Youinou Pierre Y.Diagnostic Validity of Major Salivary Gland Ultrasonography for Sjogren's Syndrome: Echostructure, Gland Size and Dppler Waveform Analysis.
Young AdamSafety and Efficacy of Etanercept Over Five Years in a Large, UK Observational Cohort.
Young DanielMathematical Modeling of Interleukin-6 Signaling Inhibition: Comparative Efficiency of Different Intervention Strategies.
Young DavidA Transcriptional Profile Present in CD4 T-Cells of Patients with Undifferentiated Arthritis Predicts the Future Development of Seronegative Rheumatoid Arthritis and Implicates IL-6 in Disease Evolution.
Young DeborahIL-21R Is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRLlprMice.
Young Jason R.Serum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring.
Young NicholasA Chimeric Human-Mouse Model of Sjogren's Syndrome.
 ZAS3 Is Overexpressed in Peripheral Blood Mononuclear Cells in Systemic Lupus Erythematosus Patients and Is Regulated by Estrogen: A Cause of the Dysreguated IL-2 Response?
Young Nicholas A.Estrogen Stimulation of Endosomal Toll-Like Receptor Expression Lowers the Threshold of Activation in Peripheral Blood Mononuclear Cells and Contributes to the Gender Bias of Systemic Lupus Erythematosus.
Yousaf WajeehaDefining Clinical Remission and Inactive Disease in Juvenile Systemic Lupus Erythematosus.
Yousefi CharleneDevelopment and Usability Testing of ANSWER: A Web-Based Methotrexate Decision Aid for Patients with Rheumatoid Arthritis.
Youssef SallyImaging As An Outcome Measure in Early Inflammatory Arthritis: Monitoring Disease Activity and Patients' Response to Therapy Using Ultrasonography.
Yow EricCD146 Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.
 A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.
Ytterberg JimmyIdentification of Shared Citrullinated Potentially Immunological Targets in the Lungs and Joints of Patients with Rheumatoid Arthritis.
Ytterberg Steven R.Increased Mortality in Giant Cell Arteritis with Large Vessel Disease: A Population-Based Cohort Study.
 Serum Proteins Reflecting Inflammation, Injury, and Repair As Biomarkers of Disease Activity in ANCA-Associated Vasculitis.
 Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?
 Distribution of Large Artery Lesions in Takayasu's Arteritis Compared to Giant Cell Arteritis.
 Relapses Among Patients with Giant Cell Arteritis.
 Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis: Which Subsets Are At Greatest Risk for Flare?
 Genome-Wide Association Study of Dermatomyositis Reveals Shared Genetic Risk Factors with Other Autoimmune Diseases.
 Type I Interferon-Related Biomarkers Predict Clinical Disease Activity in Inflammatory Myositis.
Yu AndrewUncontrolled Serum Uric Acid Is Associated with An Increased Risk of Developing Renal Disease In Veterans with Gout.
 Uncontrolled Serum Uric Acid In Veteran Gout Patients Is Associated with a Higher Risk of Diabetes.
Yu Chack-YungIncreased Frequency of Complement C4B Deficiency in Rheumatoid Arthritis (RA): Interaction with the Shared Epitope (SE).
 Risk Alleles of SLE Associated IL10 SNPs Conferred Differential Binding to Transcription Factors.
 Association of Androgen Receptor Gene Polymorphism with Damage in Systemic Lupus Erythematosus.
Yu ChengModeling Human Rheumatoid Arthritis In Non-Human Primate: Type II Collagen Induced Arthritis In Cynomolgus Macaques.
Yu Cheuk-ManInfliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial.
 Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis.
Yu FangPolymorphisms in N-Acetyltransferase 2 Impact Rheumatoid Arthritis Risk Due to Cigarette Smoking in African Americans.
Yu JianghongN-Acetylcysteine Improves Disease Activity by Blocking the Mammalian Target of Rapamycin in T Cells of Lupus Patients.
Yu Ka LungSafety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients with Systemic Lupus Erythematosus.
 Performance of Complement C3, C4 and Anti-dsDNA Antibody in Predicting Disease Flare in Systemic Lupus Erythematosus: An Analysis of Data From 6035 Clinical Visits.
 Seasonal Variation in Mortality of Six Rheumatic Diseases in Hong Kong, China: An Analysis of 2772 Deaths.
 Performance of Complement C3, C4 and Anti-dsDNA Antibody in Predicting Disease Flare in Individual Organ Systems in Systemic Lupus Erythematosus: An Analysis of Data From 6035 Clinical Visits.
Yu ShawnSerum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring.
Yu Shui LianInfliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial.
 Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis.
Yu Shui-LianUpregulated High Mobility Group Box One Acts in Synergy with Danger Signals Through the Activation of of p38 Mitogen-Activated Protein Kinases to Promote Inflammation in Patients with Lupus Nephritis.
Yu YidingPrevalence and Treatment Patterns of Psoriatic Arthritis in the Health Improvement Network.
Yu YiyunFasting Expands Regulatory T Cells in Lupus Mice.
 Leptin Promotes Th17 Responses.
Yu YongjuanA Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents.
Yu YoujunHM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice.
Yu YueVimentin Suppresses the Production of Reactive Oxygen Species and the Antimicrobial Response Via p47phox.
Yuan Jian-MinMortality Due to Coronary Heart Disease and Kidney Disease Among Middle-Aged and Elder Men and Women with Gout In the Singapore Chinese Health Study.
Yuan WeianTherapeutic Massage on Pain Relief for Fibromyalgia: A Systematic Review and Meta-Analysis.
Yuan WeijiaEffects of Fasudil Treatment on Lupus Pathogenesis in NZB/W F1 Female Mice.
Yudoh KazuoAntigenic Targets and Pathogenicity of Anti-Endothelial Cell Antibodies in Kawasaki Disease.
Yukawa NaoichiroClinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide.
Yun HuifengDoes Medication Adherence Itself Confer Fracture Protection? An Investigation of the Healthy Adherer Effect In Observational Data.
 Adherence with Intravenous Zoledronic Acid and Ibandronate for Osteoporosis Among U.S. Medicare Beneficiaries.
 Fractures and Mortality in Relation to Different Osteoporosis Treatments.
Yung SusanInhibition of Hyaluronan Synthesis with 4-Methylumbelliferone In NZBWF1/J Mice Is Associated with Improved Renal Function and Reduced Renal Inflammation.
 Binding of Serum IgG to Human Mesangial Cells and Its Correlation with Disease Activity in Patients with Lupus Nephritis.
Yurdakul SelenImpairment of the Elastic Properties of Aorta and the Carotid Artery System in Patients with Takayasu's Arteritis.
Abstract Supplement

Meeting Menu

2011 ACR/ARHP